InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
2
T+90 hit rate
0%
T+90 mean return
-1.7%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Sansone Christopher R., Director. Insider active across 1 company, notably InfuSystem Holdings, Inc. Aggregated, 3 reports have been logged. Split: 0 buy · 2 sells. Total volume traded: €1.6m. Activity tracked since 22 November 2021. The latest transaction was filed on 17 November 2022 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations3 total
40,838 shares@ US$8.1911.2% of flowCommon StockSEC:0001628280-22-030596:0
25,000 shares@ US$1.980.024% mcap1.7% of flowCommon StockSEC:0001014108-22-000062:0
80,000 shares@ US$17.730.69% mcap49.1% of flowCommon StockSEC:0001014108-21-000201:0
3 of 3 declarations
About Sansone Christopher R.
Christopher R. Sansone is a Director at InfuSystem Holdings, Inc. In this role, he contributes to the governance of the company and strategic decision-making. InfuSystem Holdings is a provider of infusion management services. Christopher's experience in the healthcare sector is valuable in guiding the company's direction.
